| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443932 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
Our results do not show a statistically significant impact of β-blocker exposure on overall survival of melanoma patients, regardless of the timing, duration or dosage of β-blocker use.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
E. Livingstone, L.M. Hollestein, M.P.P. van Herk-Sukel, L. van de Poll-Franse, T. Nijsten, D. Schadendorf, E. de Vries,